EMD Serono, Inc. Sustainability Profile
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leading biopharmaceutical company headquartered in the United States. Established in 2001, EMD Serono has made significant strides in the biotechnology sector, focusing on areas such as reproductive health, neurology, and immuno-oncology. With a strong presence in North America and Europe, the company is renowned for its innovative therapies, including cutting-edge treatments for infertility and multiple sclerosis. EMD Serono's commitment to research and development has positioned it as a key player in the biopharmaceutical industry, earning accolades for its contributions to patient care and scientific advancement. Through its unique product offerings and dedication to improving lives, EMD Serono continues to shape the future of healthcare.
DitchCarbon Score
How does EMD Serono, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
EMD Serono, Inc.'s score of 59 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
EMD Serono, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Merck KGaA, which cascades its climate commitments and performance data down to EMD Serono. As part of its parent company's initiatives, EMD Serono aligns with the sustainability goals set by Merck KGaA, which include various reduction targets and commitments to climate action. However, specific reduction targets or achievements for EMD Serono itself have not been detailed in the available data. The absence of direct emissions data suggests that EMD Serono is still in the process of establishing its own specific climate commitments, while relying on the broader framework and initiatives of Merck KGaA. This includes adherence to industry-standard climate terminology and practices, as well as potential participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are managed at the parent company level. In summary, while EMD Serono, Inc. does not currently report specific emissions data or reduction targets, it is positioned within a corporate family that is actively engaged in climate commitments through its parent company, Merck KGaA.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 352,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 000,000,000 |
| Scope 2 | 402,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is EMD Serono, Inc.'s Industry?
How Carbon Intensive is EMD Serono, Inc.'s Location?
EMD Serono, Inc.'s Scope 3 Categories Breakdown
EMD Serono, Inc.'s Scope 3 emissions, which decreased by 12% last year and increased significantly since 2010, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
EMD Serono, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
EMD Serono, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
